News and updates from www.palliativedrugs.com

Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website.   Safety updates EMA restricts metoclopramide dose and duration of use The European Medicines Agency (EMA) recommended changes to the dose and duration of use of metoclopramide in adults and children in July 2013, following a review. They […]

Read More…

News and updates from www.palliativedrugs.com

Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website.   Safety updates Updated IV Ondansetron dosing for CINV The UK MHRA has given new guidance for the administration of IV ondansetron based on further information on the risk of dose-dependent QT interval prolongation, (first reported in August […]

Read More…

News and updates from www.palliativedrugs.com

Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website.   Safety updates Codeine restricted use in children The MHRA have restricted the use of codeine in children following the results of a European safety review (see our news item 16-10-2012). Codeine is now contraindicated in: all children […]

Read More…

SHORTCUTS

Shortcuts August 2013   Support Care Cancer. 2013 Sep;21(9):2599-607 Testosterone replacement for fatigue in hypogonadal ambulatory males with advanced cancer: a preliminary double-blind placebo-controlled trial Del Fabbro E, Garcia JM, Dev R, Hui D, Williams J, Engineer D, Palmer JL, Schover L, Bruera E. In this randomized, double-blinded placebo-controlled trial the effect of testosterone replacement on […]

Read More…

SHORTCUTS

Shortcuts June 2013   Clin J Pain. 2013 Mar 26. [Epub ahead of print] Do Patient-perceived Pros and Cons of Opioids Predict Sustained Higher-Dose Use? Thielke SM, Turner JA, Shortreed SM, Saunders K, Leresche L, Campbell CI, Weisner CC, Korff MV. Using a patient completed questionnaire, this study evaluated the effect of opioids (≥50 mg […]

Read More…

News and updates from www.palliativedrugs.com

Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Safety updates Thalidomide: increased risk of haematological second primary malignancies The MHRA has highlighted the risk of haematological second primary malignancies (acute myeloid leukaemia and myelodysplastic syndromes) when treating patients with thalidomide. The data was from an ongoing study […]

Read More…

News and updates from www.palliativedrugs.com

Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Safety updates MHRA infusion device warning with 50mL syringes The UK Medicines and Healthcare products Regulatory Agency (MHRA) has issued two separate warnings of the risk of false occlusion alarms occurring with certain 50mL syringes: 50mL Luer Lok Plastipak […]

Read More…